Over the last few years, both India and the United States have voiced concerns about their high dependence on China for active pharmaceutical ingredients (APIs) and drug intermediates. A shortfall of APIs and drugs during the coronavirus pandemic exposed America's heavy reliance on India and China for a wide range of life-saving drugs.
